Institutes outside Greece
Oportunitatea corticoterapiei de scurta durata in afectiunile O.R.L.
Abstract
dc:descriptionBackground: Treatment with cortisone products has become extremely useful over the past 50-60 years. Corticosteroid therapy, in addition to its therapeutic effects, has been shown to have some adverse effects, especially in cases of repeated long-term administration at high doses, as well as after abrupt discontinuation of this treatment. In the present work, the use and benefits of short-term corticotherapy are highlighted, with extremely beneficial results and at the same time minimal side effects. Regardless of the form of administration, but mainly through the general route, it is extremely useful in a multitude of diseases of the ENT specialty, which include both the upper respiratory and digestive systems, as well as the organs belonging to the neck area or the mastoid process. There are relatively few works concerning short-term corticotherapy in ENT infections, in contrast to the use of e.g. in Dermatology or Ophthalmology. Methods: The study included a number of 8761 patients, from all counties of Moldova, during the period 1999-2005 and concerns patients admitted to the ENT clinic of the Sf Spiridon Hospital in Iaşi, during the last 7 years, examined and treated in outpatient clinics. A series of conditions for which short-term corticotherapy was administered (acute otitis externa, perichondritis, thermal burns, otic eczema, erysipelas, pyoderma, otomycosis, sarcoidosis, herpes zoster, acute and chronic serous otitis media, symphytic/secretory otitis media, acute auditory trauma, sudden hearing loss, facial nerve paralysis, peripheral vestibular-cochlear syndrome, acute rhinitis, chronic vasomotor rhinitis with accompanying alveolar hypertrophy, allergic nasal polyps, allergic sinusitis, laryngopharyngeal reflux, etc.). Treatment was also given to patients, who were operated on for diseases of the larynx or pharynx (malignant and non-malignant), extraction of foreign bodies, after intubation, rhinoplasty, nasal polyps. Results: 1. Corticosteroid therapy is a particularly useful adjunctive treatment in numerous diseases of the Otorhinolaryngology specialty. 2. Short-term treatment with corticosteroids has particular advantages over long-term treatment, as the risk of side effects is reduced. 3. Glucocorticoids stimulate the process of hepatic gluconeogenesis, resulting in increased plasma glucose, which, in turn, promotes hepatic glycogen deposition and increases insulin resistance. In terms of lipid metabolism, the effect of glucocorticoids is to redistribute body fat and facilitate the effects of lipolytic agents. Large doses of glucocorticoids lead to a redistribution of fat in the upper trunk and face, with simultaneous loss of fat in the extremities. 4. In protein metabolism, corticosteroids favor the catabolism of proteins, converting them to glycogen, resulting in negative nitrogen balance, which is rarely seen in short-term corticosteroid therapy. 5. On what reffers to electrolytes, corticosteroids in long-term use alone increase glomerular filtration rate and renal plasma flow, increasing phosphate excretion, as well as increasing sodium and water retention and, respectively, potassium excretion, acting on receptors of corticosteroids. 6. Regarding the anti-allergic effect, glucocorticoids do not prevent the antigen-antibody reaction, nor the release of histamine, however they affect the action of histamine and serotonin, they modify the tissue reaction to inflammation, a phenomenon that is observed mainly in the first days of administration, thus constituting an additional, significant advantage to short-term cortisone administration. 7. The anti-inflammatory effect of glucocorticoids, in the initial phase of treatment, lies in the significant reduction of swelling, the normalization of the sedimentation rate of red blood cells, the reduction of C-reactive protein, the inhibition of collagen production, the fall of fever, as well as and in the reduction and even disappearance of local inflammatory phenomena. It also reduces phagocytosis and favors the migration of leukocytes from the inflammatory focus. 8. Glucocorticoids beneficially affect the connective tissue, suppressing its action, through increasing the degree of polymerization of hyaluronic acid. In the case of strictures of the pharynx, larynx and esophagus, cortisone treatment prevents fibroblasts from forming granulation tissue, delaying scar formation. 9. Regarding the route of administration, short-term treatment with corticosteroids (1-5 days) has obvious beneficial effects, when the route of use is systemic (oral administration, intravenous or intramuscular injections), especially in inflammatory and infectious diseases of the pharynx, larynx but also of the thyroid.10. In the local administration of short-term corticotherapy, obvious results are achieved in the inflammatory processes of the external ear, in certain forms of allergic rhinitis and in acute pharyngitis. Intratympanic cortisone infusions are mainly performed in patients with persistent tinnitus, sudden hearing loss, who cannot tolerate oral treatment or suffer from diabetes mellitus, immunosuppression or do not respond to systemic therapy and are sometimes combined with antibiotics (e.g. with gentamicin, in Meniere's disease) and mucolytics. In acute sinusitis, the administration of cortisone along with antibiotic treatment, after flushing the sinuses, also has an extremely beneficial effect. Supraorbital, suborbital, occipital neuralgias benefit from the prescription of cortisone preparations. A number of adverse effects of corticoids such as fluid retention, arterial hypertension, edema, onset of diabetes or myopathy, osteoporosis, increased protein catabolism, neuropsychiatric disorders (euphoria, insomnia, agitation, convulsions, behavioral disorders, psychiatric manifestations, psychological dependence) gastroduodenal ulcer, adrenocortical insufficiency, reduced resistance to infections and increased intraocular pressure are almost absent in short-term treatment with corticosteroids, finding them in only 1.5-2% of cases
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Visvardis, Ioannis
- Βισβάρδης, Ιωάννης
Subjects
dc:subject × 13Rights
- Language dc:language
- rom
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/56574